Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Toxic Shock Syndrome
Scientists Contribute to the Development of Potential Therapeutics for Toxic Shock Syndrome
July 22nd, 2007
Published in this month's issue of the journal Nature Medicine, a collaborative team of scientists from the University of Illinois, the University of Minnesota Medical School and the Boston Biomedical Research Institute describe engineered proteins that completely neutralize the lethal activity of a bacterial superantigen in animal models. Their work holds great promise for the development of new therapeutics for toxic shock syndrome, a condition that is characterized by high fever and hypotension and can lead to multi-organ failure and death, and for which no treatment is currently available. The research team, led by David M. Kranz from the University of Illinois and...
Source: Medical Devices & Surgical Technology Week (2007-07-22)
|
